RESUMO
Urticaria pigmentosa is a rare dermatologic syndrome in humans, cats, and dogs. This report documents a case of canine urticaria pigmentosa-like disease with unusual features and no C-kit mutation.
Maladie s'apparentant à l'urticaire pigmentaire chez un chien. L'urticaire pigmentaire est un syndrome dermatologique rare chez les humains, les chats et les chiens. Ce rapport documente un cas canin s'apparentant à l'urticaire pigmentaire comportant des caractéristiques inhabituelles et l'absence de mutation C-kit.(Traduit par Isabelle Vallières).
Assuntos
Doenças do Cão/patologia , Urticaria Pigmentosa/veterinária , Animais , Antialérgicos/administração & dosagem , Antialérgicos/uso terapêutico , Antiulcerosos/administração & dosagem , Antiulcerosos/uso terapêutico , Cetirizina/administração & dosagem , Cetirizina/uso terapêutico , Difenidramina/administração & dosagem , Difenidramina/uso terapêutico , Doenças do Cão/diagnóstico , Cães , Famotidina/administração & dosagem , Famotidina/uso terapêutico , Masculino , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/tratamento farmacológico , Urticaria Pigmentosa/patologiaRESUMO
PRACTICAL RELEVANCE: Feline cutaneous lymphocytosis is a rare disease characterized by proliferation of T and/or B lymphocytes in the dermis. Although some of the clinical and histopathologic findings of this condition can overlap with cutaneous lymphoma, it is important to distinguish these entities since their treatment and clinical outcomes vary greatly. SCOPE: This report presents a summary of the literature on feline cutaneous lymphocytosis and describes a case of this condition which showed some unique clinical features and was successfully controlled with oral glucocorticoids.
Assuntos
Doenças do Gato/patologia , Glucocorticoides/uso terapêutico , Linfocitose/veterinária , Administração Oral , Alopecia/complicações , Alopecia/patologia , Alopecia/veterinária , Animais , Linfócitos B/patologia , Doenças do Gato/tratamento farmacológico , Gatos , Diagnóstico Diferencial , Eritema/complicações , Eritema/tratamento farmacológico , Eritema/patologia , Eritema/veterinária , Glucocorticoides/administração & dosagem , Linfocitose/complicações , Linfocitose/tratamento farmacológico , Linfocitose/patologiaRESUMO
A 3 yr old, 70 kg (154 lbs) female spayed Great Dane developed gingival hyperplasia after treatment of systemic hypertension with amlodipine 7.5 mg q 12 hr for 16 mo. Physical examination was unremarkable except for systemic hypertension and severe gingival hyperplasia. Amlodipine was replaced with hydralazine (0.72 mg/kg [0.32 mg/lb]). Nine months later, gingival hyperplasia was nearly resolved and hypertension was well controlled. Calcium channel blockers such as amlodipine are a rare cause of gingival hyperplasia in the canine patient. Recognition of this side effect is important because a full recovery can be achieved when the offending agent is removed.
